Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Inhibikase Therapeutics Inc IKT

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing therapeutics for Parkinson’s disease and related disorders. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program risvodetinib (also known as IkT-148009), an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson’s disease... see more

Bullboard (NDAQ:IKT)

View:
Post by whytestockson Nov 08, 2024 10:30am

IKT Price Target Alert: $8.00. Issued by Jefferies

Just In: $IKT IKT Price Target Alert: $8.00. Issued by Jefferies2024-11-08 05:14:25 ET Dennis Ding from Jefferies issued a price target of $8.00 for IKT on 2024-11-08 08:22:00. The adjusted price ...more  
Post by whytestockson Oct 21, 2024 12:18pm

Inhibikase Therapeutics Announces Closing of up to $275 Mill

Just In: $IKT Inhibikase Therapeutics Announces Closing of up to $275 Million Financing and Advancement of IkT-001Pro into a Late Stage Clinical Trial in Pulmonary Arterial Hypertension-- IkT-001Pro ...more  
Post by MikeTesteron Aug 02, 2024 6:16am

Inhibikase Therapeutics, Inc. (NASDAQ:IKT): Advancing Innova

https://beyondspx.com/2024/08/01/inhibikase-therapeutics-inc-nasdaqikt-advancing-innovative-therapies-for-parkinsons-and-beyond/
Post by whytestockson May 20, 2024 3:30pm

Inhibikase Therapeutics Announces Pricing of Registered Dire

News; $IKT Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 MillionBOSTON and ATLANTA, May 20 ...more  
Post by Iseneschalon Mar 16, 2023 9:10am

My U.S w/l this a.m......

CS....HUBC...IKT...LIPO...THMO
Post by Iseneschalon Mar 08, 2023 10:19am

IKT ....Vols have declined

JUst an observation...no position Still watching !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities